Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia

D. R. Illingworth, W. E. Connor, L. F. Hatcher, William Harris

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The influence of fish oils rich in n-3 fatty acids on plasma lipid and lipoprotein concentrations in patients with primary hyperlipoproteinaemia is reviewed. When used as a dietary supplement, n-3 fatty acids exert their greatest effect on the concentrations of triglyceride-rich lipoproteins and these effects are dose dependent. Low doses of n-3 fatty acids reduce plasma triglyceride concentrations in patients with phenotypic type IV, type V and type IIB hyperlipoproteinaemia, but concurrently result in modest increases in the plasma concentrations of low density lipoprotein (LDL). With very high doses plasma concentrations of LDL cholesterol decrease in patients with the type IIB phenotype. At low doses n-3 fatty acids do not significantly lower concentrations of LDL cholesterol in patients with primary hypercholesterolaemia whereas at higher doses a modest LDL lowering effect is achieved. The results indicate that the therapeutic potential of n-3 fatty acids as hypolipidaemic agents is greatest in patients with hypertriglyceridaemia.

Original languageEnglish (US)
Pages (from-to)91-97
Number of pages7
JournalJournal of Internal Medicine
Volume225
Issue numberS731
DOIs
StatePublished - Dec 1989

Fingerprint

Hyperlipoproteinemias
Omega-3 Fatty Acids
LDL Lipoproteins
LDL Cholesterol
Lipoproteins
Hyperlipoproteinemia Type V
Triglycerides
Hypolipidemic Agents
Fish Oils
Hypertriglyceridemia
Dietary Supplements
Hypercholesterolemia
Phenotype
Lipids

Keywords

  • Dietary fatty acids
  • Familial hypercholesterolaemia
  • Fish oils
  • Hypolipidaemic agents
  • Lipoproteins
  • Type III hyperlipoproteinaemia

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia. / Illingworth, D. R.; Connor, W. E.; Hatcher, L. F.; Harris, William.

In: Journal of Internal Medicine, Vol. 225, No. S731, 12.1989, p. 91-97.

Research output: Contribution to journalArticle

Illingworth, D. R. ; Connor, W. E. ; Hatcher, L. F. ; Harris, William. / Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia. In: Journal of Internal Medicine. 1989 ; Vol. 225, No. S731. pp. 91-97.
@article{d68574261b7d423da90eff766a630886,
title = "Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia",
abstract = "The influence of fish oils rich in n-3 fatty acids on plasma lipid and lipoprotein concentrations in patients with primary hyperlipoproteinaemia is reviewed. When used as a dietary supplement, n-3 fatty acids exert their greatest effect on the concentrations of triglyceride-rich lipoproteins and these effects are dose dependent. Low doses of n-3 fatty acids reduce plasma triglyceride concentrations in patients with phenotypic type IV, type V and type IIB hyperlipoproteinaemia, but concurrently result in modest increases in the plasma concentrations of low density lipoprotein (LDL). With very high doses plasma concentrations of LDL cholesterol decrease in patients with the type IIB phenotype. At low doses n-3 fatty acids do not significantly lower concentrations of LDL cholesterol in patients with primary hypercholesterolaemia whereas at higher doses a modest LDL lowering effect is achieved. The results indicate that the therapeutic potential of n-3 fatty acids as hypolipidaemic agents is greatest in patients with hypertriglyceridaemia.",
keywords = "Dietary fatty acids, Familial hypercholesterolaemia, Fish oils, Hypolipidaemic agents, Lipoproteins, Type III hyperlipoproteinaemia",
author = "Illingworth, {D. R.} and Connor, {W. E.} and Hatcher, {L. F.} and William Harris",
year = "1989",
month = "12",
doi = "10.1111/j.1365-2796.1989.tb01441.x",
language = "English (US)",
volume = "225",
pages = "91--97",
journal = "Journal of Internal Medicine",
issn = "0954-6820",
publisher = "Wiley-Blackwell",
number = "S731",

}

TY - JOUR

T1 - Hypolipidaemic effects of n-3 fatty acids in primary hyperlipoproteinaemia

AU - Illingworth, D. R.

AU - Connor, W. E.

AU - Hatcher, L. F.

AU - Harris, William

PY - 1989/12

Y1 - 1989/12

N2 - The influence of fish oils rich in n-3 fatty acids on plasma lipid and lipoprotein concentrations in patients with primary hyperlipoproteinaemia is reviewed. When used as a dietary supplement, n-3 fatty acids exert their greatest effect on the concentrations of triglyceride-rich lipoproteins and these effects are dose dependent. Low doses of n-3 fatty acids reduce plasma triglyceride concentrations in patients with phenotypic type IV, type V and type IIB hyperlipoproteinaemia, but concurrently result in modest increases in the plasma concentrations of low density lipoprotein (LDL). With very high doses plasma concentrations of LDL cholesterol decrease in patients with the type IIB phenotype. At low doses n-3 fatty acids do not significantly lower concentrations of LDL cholesterol in patients with primary hypercholesterolaemia whereas at higher doses a modest LDL lowering effect is achieved. The results indicate that the therapeutic potential of n-3 fatty acids as hypolipidaemic agents is greatest in patients with hypertriglyceridaemia.

AB - The influence of fish oils rich in n-3 fatty acids on plasma lipid and lipoprotein concentrations in patients with primary hyperlipoproteinaemia is reviewed. When used as a dietary supplement, n-3 fatty acids exert their greatest effect on the concentrations of triglyceride-rich lipoproteins and these effects are dose dependent. Low doses of n-3 fatty acids reduce plasma triglyceride concentrations in patients with phenotypic type IV, type V and type IIB hyperlipoproteinaemia, but concurrently result in modest increases in the plasma concentrations of low density lipoprotein (LDL). With very high doses plasma concentrations of LDL cholesterol decrease in patients with the type IIB phenotype. At low doses n-3 fatty acids do not significantly lower concentrations of LDL cholesterol in patients with primary hypercholesterolaemia whereas at higher doses a modest LDL lowering effect is achieved. The results indicate that the therapeutic potential of n-3 fatty acids as hypolipidaemic agents is greatest in patients with hypertriglyceridaemia.

KW - Dietary fatty acids

KW - Familial hypercholesterolaemia

KW - Fish oils

KW - Hypolipidaemic agents

KW - Lipoproteins

KW - Type III hyperlipoproteinaemia

UR - http://www.scopus.com/inward/record.url?scp=0024365380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024365380&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2796.1989.tb01441.x

DO - 10.1111/j.1365-2796.1989.tb01441.x

M3 - Article

C2 - 2650700

AN - SCOPUS:0024365380

VL - 225

SP - 91

EP - 97

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0954-6820

IS - S731

ER -